Ditchcarbon
  • Contact
  1. Organizations
  2. RBC Life Sciences, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated a month ago

RBC Life Sciences, Inc. Sustainability Profile

Company website

RBC Life Sciences, Inc., a prominent player in the biotechnology and life sciences sector, is headquartered in the United States. Founded in 1997, the company has established itself as a leader in the development and distribution of innovative health products, particularly in the fields of nutritional supplements and diagnostic testing. With a focus on enhancing health and wellness, RBC Life Sciences offers a unique range of core products, including proprietary formulations that cater to various health needs. The company’s commitment to quality and scientific research has positioned it favourably in the competitive life sciences market. Notable achievements include significant advancements in product efficacy and a growing presence in key operational regions across North America.

DitchCarbon Score

How does RBC Life Sciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

29

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

RBC Life Sciences, Inc.'s score of 29 is lower than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.

48%

Let us know if this data was useful to you

RBC Life Sciences, Inc.'s reported carbon emissions

RBC Life Sciences, Inc., headquartered in the US, currently does not report any specific carbon emissions data. However, the company has established significant climate commitments aimed at reducing its carbon footprint. RBC Life Sciences has set ambitious near-term reduction targets, aiming for a 36% reduction in absolute emissions for both Scope 1 and Scope 2 by 2030, compared to 2020 levels. This aligns with broader targets set by developed economies, including the EU and the US. In addition to these near-term goals, the company has also committed to long-term net-zero targets for Scope 1 and Scope 2 emissions, with a timeframe extending to 2060. This commitment reflects a growing trend among companies to align with global climate initiatives and the targets set by emerging economies in the region. While specific emissions data is not available, RBC Life Sciences' proactive approach to climate commitments demonstrates its dedication to sustainability and reducing its environmental impact.

How Carbon Intensive is RBC Life Sciences, Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. RBC Life Sciences, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is RBC Life Sciences, Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for RBC Life Sciences, Inc. is in US, which has a low grid carbon intensity relative to other regions.

RBC Life Sciences, Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

RBC Life Sciences, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare RBC Life Sciences, Inc.'s Emissions with Industry Peers

Swanson Health Products, Inc.

US
•
Food products nec
Updated 18 days ago

Herbalife

US
•
Pharmaceutical Preparation Manufacturing
Updated 18 days ago

Forever Living Products International, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 18 days ago

Vitamin Shoppe Industries Inc.

US
•
Food products nec
Updated about 2 months ago

F. Hoffmann-La Roche AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 16 days ago

Thermo Fisher Scientific

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 6 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251120.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy